You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dose escalation

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)

Completed
Has Results
  • Helicobacter Pylori Infection
  • New York, New York
    Mount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023

Safety Issues Trial in Hialeah (EQU-001, Placebo)

Completed
  • Safety Issues
  • Hialeah, Florida
    Clinical Pharmacology of Miami
Jan 31, 2023

Ovarian Cancer Trial in Turku (KAND145, Placebo)

Not yet recruiting
  • Ovarian Cancer
  • Turku, Finland
    Clinical Research Services Turku - CRST Oy
Sep 26, 2023

Colorectal Cancer Trial (ME-344, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Hepatic Impairment Trial (Apraglutide)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Jan 20, 2023

Bacterial Infection Trial in Knoxville (Apramycin (EBL-1003))

Not yet recruiting
  • Bacterial Infection
  • Apramycin (EBL-1003)
  • Knoxville, Tennessee
    Alliance for Multispecialty Research, LLC - Knoxville
Feb 2, 2023

Rectal Cancer Trial in Seoul (Temozolomide)

Completed
Has Results
  • Rectal Cancer
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

Paroxysmal Nocturnal Hemoglobinuria Trial in Adelaide (KP104, Placebo)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Adelaide, Australia
    CMAX Clinical Research
Aug 4, 2022

Anxiety, Neurasthenia, Adjustment Disorders Trial in Russian Federation (Ranquilon, Placebo)

Recruiting
  • Anxiety
  • +2 more
  • Engels, Russian Federation
  • +10 more
Oct 14, 2022

Hepatic Impairment Trial in Orlando, Knoxville (CTP-543)

Recruiting
  • Hepatic Impairment
  • Orlando, Florida
  • +1 more
Jul 18, 2022

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

Brain Tumor Trial in Beijing (GB222 3mg/kg, GB222 5mg/kg, GB222 7.5mg/kg)

Unknown status
  • Brain Tumor
  • GB222 3mg/kg
  • +3 more
  • Beijing, Beijing, China
    Beijing Tiantan Hospital of Capital Medical University
Nov 25, 2019

REM Sleep Behavior Disorder Trial in Camperdown, Oxford (PXS-4728 (A), Matching Placebo (B))

Not yet recruiting
  • REM Sleep Behavior Disorder
  • PXS-4728 (A)
  • Matching Placebo (B)
  • Camperdown, Sydney, Australia
  • +1 more
Jun 6, 2023

Postbariatric Hypoglycemia Trial (Mizagliflozin)

Not yet recruiting
  • Postbariatric Hypoglycemia
  • (no location specified)
Jan 31, 2023

Gastrointestinal Dysfunction Trial in Dombivli, Nashik, Pune (EF2001 (Low dose), EF2001 (High dose), beLP1 (Low dose))

Not yet recruiting
  • Gastrointestinal Dysfunction
  • EF2001 (Low dose)
  • +4 more
  • Dombivli, Maharashtra, India
  • +5 more
Apr 6, 2023

Recurrent Rectal Cancer Trial in Saint Louis (Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy, MEVION

Recruiting
  • Recurrent Rectal Cancer
  • Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy
  • MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 8, 2022

Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine)

Active, not recruiting
  • Healthy Volunteers
  • Irbesartan/Amlodipine FDC
  • +2 more
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
Jan 8, 2023

Exocrine Pancreatic Cancer Trial in Oklahoma City (Omeprazole)

Recruiting
  • Exocrine Pancreatic Cancer
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jan 9, 2023

Essential Hypertension Trial in Worldwide (Aprocitentan 5 mg, Aprocitentan 10 mg, Aprocitentan 25 mg)

Completed
Has Results
  • Essential Hypertension
  • Aprocitentan 5 mg
  • +5 more
  • Fort Payne, Alabama
  • +90 more
Nov 22, 2022

COVID-19 Trial in Randwick (STI-1558, Placebo)

Completed
  • COVID-19
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Jan 26, 2023

Vitamin D Deficiency Trial in Warszawa (Cholecalciferol 120 000 IU)

Completed
  • Vitamin D Deficiency
  • Cholecalciferol 120 000 IU
  • Warszawa, Poland
    Department of Endocrinology, Centre of Postgraduate Medical Educ
Oct 19, 2022

Aicardi-Goutières Syndrome (AGS) Trial in France, Italy, United Kingdom (TPN-101)

Not yet recruiting
  • Aicardi-Goutières Syndrome (AGS)
  • Paris, France
  • +4 more
Nov 10, 2022

Lymphoma, Solid Tumor Trial in Hamilton, Toronto (CDKI AT7519, laboratory biomarker analysis)

Completed
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • CDKI AT7519
  • laboratory biomarker analysis
  • Hamilton, Ontario, Canada
  • +1 more
Apr 6, 2020

Chronic Heart Failure Trial in Poland, United Kingdom (mRNA-0184, Placebo)

Recruiting
  • Chronic Heart Failure
  • Wroclaw, Dolnoslaskie, Poland
  • +5 more
Dec 13, 2022

Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

Not yet recruiting
  • Hematologic Malignancy
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 6, 2023